Position in IBRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,132,730
-$121,867 QoQ
Shares Held
129,381
-20.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#102
of 403 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $23,738,174 across 21 Biotechnology names. IBRX ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,400 | $9,139,832 | |
| 2 | ANAB |
Anaptysbio, Inc
|
42,761 | $2,886,367 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12,538 | $1,536,908 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
14,793 | $1,172,936 | |
| 5 | IBRX |
ImmunityBio, Inc.
This page
|
129,381 | $1,132,730 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
11,638 | $1,011,924 | |
| 7 | BCAX |
Bicara Therapeutics Inc.
|
29,181 | $866,383 | |
| 8 | RPRX |
Royalty Pharma plc
|
14,626 | $820,079 |
All Filings in IBRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,132,730 | 129,381 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,254,597 | 163,572 | Shares | Sole | 2026-05-04 | |
| 2024-12-31 | $36,083 | 14,095 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $59,307 | 15,943 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $99,893 | 15,806 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $58,119 | 10,823 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||